Difference between revisions of "US PA Philadelphia Falk MJ"
From Bioblast
| Line 14: | Line 14: | ||
|MiPNetLab=Polyak E | |MiPNetLab=Polyak E | ||
|Status=O2k 2008- | |Status=O2k 2008- | ||
|info=[http://www.oroboros.at/?IOC47 IOC47] | |info=[[MiPNet19.06 IOC 2014-06 Philadelphia | IOC91 Philadelphia]], [http://www.oroboros.at/?IOC47 IOC47] | ||
|keyword=Respiratory OXPHOS disease | |keyword=Respiratory OXPHOS disease | ||
}} | }} | ||
Revision as of 19:41, 29 May 2014
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ
